Keeping a lid on drug prices is proving costly for ambitions to turn the UK into a life sciences superpower ...

The pharmaceutical industry is bracing for potentially major disruptions following US President Donald Trump’s announcement ...

Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...

Madhya Pradesh Chief Minister Mohan Yadav courted business leaders in countries ranging from the UK to Japan as well as ...

As the leader of an American company based in the UK, it is important that we acknowledge ... To attract employees with diverse backgrounds, companies need to demonstrate their purpose – at ...

The UK's voluntary system for disclosing payments from pharma companies to healthcare professionals ... tip of the iceberg when it comes to drug company payments to healthcare professionals ...

The recent acquisitions by pharmaceutical giants Johnson & Johnson and Bristol Myers Squibb, worth a combined $28billion, ...

Sir Keir Starmer is driving the UK into “irrelevance”, the boss of one of Britain’s fastest-growing healthcare companies has ...

The FTSE 100 finished up 103.99 at 8727.28 - a new record closing high. It also hit a new intraday record of 8,767.50 earlier ...

Inside AstraZeneca’s abandoned UK vaccine plant deal as Labour and Tories face questions over £450m collapse - AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl M ...

Welcome to Fierce Pharma's regulatory tracker for the first ... CHMP opinion," the partners said in a Friday press release. The companies didn't reveal the nature of the new safety information ...

Mallya has moved the high court for data on the total debt recovery made from him by banks. In this article, how the fugitive ...